Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.

Mészáros M, Phan THM, Vigh JP, Porkoláb G, Kocsis A, Szecskó A, Páli EK, Cser NM, Polgár TF, Kecskeméti G, Walter FR, Schwamborn JC, Janáky T, Jan JS, Veszelka S, Deli MA

Open source

DOI
10.1186/s12987-025-00623-2
Published
2025 Feb 19
Container
Fluids and barriers of the CNS
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12987-025-00623-2,
  title = {Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.},
  author = {Mészáros M and Phan THM and Vigh JP and Porkoláb G and Kocsis A and Szecskó A and Páli EK and Cser NM and Polgár TF and Kecskeméti G and Walter FR and Schwamborn JC and Janáky T and Jan JS and Veszelka S and Deli MA},
  year = {2025},
  journal = {Fluids and barriers of the CNS},
  doi = {10.1186/s12987-025-00623-2},
  url = {https://doi.org/10.1186/s12987-025-00623-2}
}

RIS

TY  - JOUR
TI  - Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.
AU  - Mészáros M
AU  - Phan THM
AU  - Vigh JP
AU  - Porkoláb G
AU  - Kocsis A
AU  - Szecskó A
AU  - Páli EK
AU  - Cser NM
AU  - Polgár TF
AU  - Kecskeméti G
AU  - Walter FR
AU  - Schwamborn JC
AU  - Janáky T
AU  - Jan JS
AU  - Veszelka S
AU  - Deli MA
PY  - 2025
JO  - Fluids and barriers of the CNS
DO  - 10.1186/s12987-025-00623-2
UR  - https://doi.org/10.1186/s12987-025-00623-2
ER  - 

APA

M, M., THM, P., JP, V., G, P., A, K., A, S., EK, P., NM, C., TF, P., G, K., FR, W., JC, S., T, J., JS, J., S, V., & MA, D. (2025). Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.. Fluids and barriers of the CNS. https://doi.org/10.1186/s12987-025-00623-2

Source records